Inhibitex Inc. (INHX) Stock Quote

Detailed Quote for Inhibitex Inc. (INHX) 
$ 25.96   0.06 (+0.23%) Volume: 1.35 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 25.97   0.01 (+0.04%) Volume: 1,000  4:16 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
25.96
Change $
0.06
Change %
0.23%
Tick
N/A
Bid
25.95
Bid Size
500
Ask
25.97
Ask Size
6,200
Open
25.91
High
25.96
Low
25.91
Prev Close
25.90
Last Trade
4:00
Volume
1.35 m
52 Wk Hi
25.96
52 Wk Low
2.15
Market Cap
2.03 b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
78,293,482
EPS (TTM)
-0.38
PE Ratio
N/A
Exchange
NSC
News and Media for Inhibitex Inc.  (INHX) 
Sector News | Topic News
News for INHX
Tue, Feb 07, 2012
9:00 AM A Forward Look, the Year Ahead - Featured Research on Inhibitex, Inc. and Idenix Pharmaceuticals, Inc. - Marketwire
Thu, Jan 19, 2012
11:28 AM Bull & Lifshitz, LLP Announces Investigation of Inhibitex, Inc. - PR Newswire
Fri, Jan 13, 2012
2:08 PM The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. in Connection With the Sale of the Company to Bristol-Myers Squibb Co. - Marketwire
Wed, Jan 11, 2012
11:50 AM Potentially Unfair Tender Offer for Inhibitex Triggers Shareholder-Claim Investigation by Securities Class Action Lawyers at Goldfarb Branham LLP - PR Newswire
Tue, Jan 10, 2012
7:06 PM The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Co. - Business Wire
7:00 PM Faruqi & Faruqi, LLP Announces Investigation of Inhibitex, Inc. - Business Wire
3:57 PM Law Firm Brower Piven Announces Investigation of Inhibitex, Inc. - Business Wire
10:37 AM Ryan & Maniskas, LLP Announces Investigation of Inhibitex, Inc. - Business Wire
Mon, Jan 09, 2012
7:03 PM Law Offices of Howard G. Smith Announces Investigation of Inhibitex, Inc. - Business Wire
4:02 PM Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inhibitex, Inc. - Business Wire
1:10 PM Harwood Feffer LLP Announces Investigation of Inhibitex, Inc. - Business Wire
1:06 PM Glancy Binkow & Goldberg LLP Announces Investigation of Inhibitex, Inc. - Business Wire
11:21 AM The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Co. - Business Wire
11:02 AM Inhibitex, Inc. Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Inhibitex, Inc. Concerning the Sale of INHX to Bristol-Myers Squibb - PR Newswire
9:50 AM Rigrodsky & Long, P.A. Announces Investigation of Inhibitex, Inc.'s Agreement to be Acquired by Bristol-Myers Squibb Company - Business Wire
Sat, Jan 07, 2012
9:13 PM Bristol-Myers Squibb to Acquire Inhibitex - Business Wire
Thu, Dec 01, 2011
6:27 PM Inhibitex to Participate in the 2011 Deutsche Bank BioFEST - Business Wire
Tue, Nov 29, 2011
7:00 AM Inhibitex Reports Recent Clinical and Corporate Developments - Business Wire
Tue, Nov 22, 2011
9:00 AM Direction of Market Influences - Report Highlights Inhibitex, Inc. and Invesco Ltd. - Marketwire
Tue, Nov 08, 2011
8:16 AM Promising Studies From Inhibitex Take Wind Out of Vertex Pharmaceutical's Sails - Marketwire
More News for INHX >>

Tags for Inhibitex Inc.

Research stocks or mutual funds related to Inhibitex Inc. by keywords or tags. Find companies that have a similar focus to INHX. The keywords below have been associated to INHX by either user submission or electronic means.

antimicrobial treatment antibiotics mrsa treatment for shingles generic pharmaceutical shingles chickenpox shingles symptoms pharmaceutical investment biotechnology market shingles pregnancy herpes shingles antimicrobial resistance pharmaceutical manufacturing company Biological Products pharmaceutical software pharma manufacturing pharmaceutical clinical research shingles children pfizer pharmaceutical company medical condition shingles herpes zoster shingles pharmaceutical cro biopharmaceutical companies adult chicken pox pharma companies chicken pox scars clinical trials industry pharmaceutical distributors shingles medical biotech corporation pharmaceutical development biopharmaceutical company shingles contagious pharmaceutical production pharmaceutical consultant Drugs pharmaceutical auctions symptoms of shingles chicken pox adults health shingles pharma clinical trials pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference clinical trials conference bacteria infections herpes pharmaceutical manufacturing pharmaceutical formulation chicken pox symptoms medical device clinical trial